Novavax (NVAX) Receivables - Net (2010 - 2026)
Novavax (NVAX) posted quarterly Receivables - Net of $23.3 million for Q1 2026, down 55.33% year-over-year from $52.2 million in Q1 2025, and down 75.62% quarter-over-quarter from $95.6 million in Q4 2025.
Novavax (NVAX) Receivables - Net (2010 - 2026) Analysis & Trends
Novavax's Receivables - Net history runs 15 years deep, the most recent figure standing at $23.3 million for Q1 2026.
- In Q1 2026, Receivables - Net fell 55.33% year-over-year to $23.3 million; the TTM figure through Mar 2026 stood at $23.3 million (down 55.33% YoY), while the FY2025 annual figure was $106.4 million, down 8.2% from the prior year.
- Receivables - Net for Q1 2026 stood at $23.3 million, down from $95.6 million in the prior quarter.
- The five-year high for Receivables - Net was $478.2 million in Q1 2022, with the low at $23.3 million in Q1 2026.
- The 5-year median for Receivables - Net is $111.6 million (2022), against an average of $151.8 million.
- The sharpest annual moves came in 2022 and 2024: Receivables - Net surged 740.37% in 2022, then sank 90.12% in 2024.
- Novavax's Receivables - Net stood at $96.2 million in 2022, then surged by 216.93% to $304.9 million in 2023, then sank by 61.97% to $116.0 million in 2024, then retreated by 17.56% to $95.6 million in 2025, then plunged by 75.62% to $23.3 million in 2026.
- Business Quant data shows NVAX's Receivables - Net at $23.3 million in Q1 2026, $95.6 million in Q4 2025, and $41.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Novavax | 1.33 Bn | 607.37 Mn | 42.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 18.74 Mn |
| Jun 30, 2026 | 18.74 Mn |
| Mar 31, 2026 | 23.31 Mn |
| Mar 31, 2026 | 23.31 Mn |
| Dec 31, 2025 | 95.60 Mn |
| Dec 31, 2025 | 95.60 Mn |
| Sep 30, 2025 | 41.85 Mn |
| Sep 30, 2025 | 41.85 Mn |
| Jun 30, 2025 | 234.07 Mn |
| Jun 30, 2025 | 234.07 Mn |
| Mar 31, 2025 | 52.19 Mn |
| Mar 31, 2025 | 52.19 Mn |
| Dec 31, 2024 | 115.96 Mn |
| Dec 31, 2024 | 115.96 Mn |
| Sep 30, 2024 | 102.64 Mn |
| Sep 30, 2024 | 102.64 Mn |
| Jun 30, 2024 | 39.78 Mn |
| Jun 30, 2024 | 39.78 Mn |
| Mar 31, 2024 | 29.06 Mn |
| Mar 31, 2024 | 29.06 Mn |